Select Medical (NYSE:SEM) Stock Rating Upgraded by StockNews.com

Select Medical (NYSE:SEM) was upgraded by equities researchers at StockNews.com from a “hold” rating to a “buy” rating in a research note issued on Wednesday.

Several other research firms have also issued reports on SEM. Benchmark restated a “buy” rating and issued a $48.00 price objective on shares of Select Medical in a research note on Friday, November 1st. Royal Bank of Canada increased their target price on Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a research note on Monday, November 4th. Finally, Bank of America began coverage on Select Medical in a research note on Tuesday, August 20th. They set a “buy” rating and a $42.00 target price on the stock. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat, Select Medical presently has a consensus rating of “Moderate Buy” and a consensus target price of $40.75.

Select Medical Trading Down 2.5 %

SEM stock opened at $37.24 on Wednesday. The company has a market cap of $4.82 billion, a P/E ratio of 17.41, a PEG ratio of 2.04 and a beta of 1.42. Select Medical has a twelve month low of $22.26 and a twelve month high of $40.98. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37. The business has a fifty day moving average of $34.69 and a 200-day moving average of $34.64.

Select Medical (NYSE:SEM) last released its quarterly earnings data on Thursday, October 31st. The health services provider reported $0.43 EPS for the quarter, beating analysts’ consensus estimates of $0.36 by $0.07. The business had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.74 billion. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The firm’s revenue was up 5.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.46 earnings per share. As a group, equities research analysts expect that Select Medical will post 2.16 EPS for the current year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the stock. Hexagon Capital Partners LLC raised its position in shares of Select Medical by 528.7% in the 2nd quarter. Hexagon Capital Partners LLC now owns 767 shares of the health services provider’s stock worth $27,000 after acquiring an additional 645 shares in the last quarter. Transcendent Capital Group LLC bought a new position in shares of Select Medical in the 2nd quarter worth about $35,000. Canada Pension Plan Investment Board bought a new stake in Select Medical in the 2nd quarter valued at about $39,000. DekaBank Deutsche Girozentrale bought a new stake in Select Medical in the 2nd quarter valued at about $60,000. Finally, GAMMA Investing LLC increased its position in Select Medical by 52.8% in the 2nd quarter. GAMMA Investing LLC now owns 1,983 shares of the health services provider’s stock valued at $70,000 after buying an additional 685 shares in the last quarter. 89.48% of the stock is owned by institutional investors.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.